RECOMBINANT ERYTHROPOIETIN THERAPY IN CANCER-PATIENTS

被引：18

作者：

BUNN, HF

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1990年 / 8卷 / 06期

关键词：

D O I：

10.1200/JCO.1990.8.6.949

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：949 / 951

页数：3

共 21 条

[1] BLUNTED ERYTHROPOIETIN RESPONSE TO ANEMIA IN RHEUMATOID-ARTHRITIS
BAER, AN
DESSYPRIS, EN
GOLDWASSER, E
KRANTZ, SB
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) : 559 - 564
[2] MARKED ERYTHROPOIETIN INCREASE BEFORE FALL IN HB AFTER TREATMENT WITH CYTOSTATIC DRUGS SUGGESTS MECHANISM OTHER THAN ANEMIA FOR STIMULATION
BIRGEGARD, G
WIDE, L
SIMONSSON, B
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (03) : 462 - 466
[3] EXPRESSION CLONING OF THE MURINE ERYTHROPOIETIN RECEPTOR
DANDREA, AD
LODISH, HF
WONG, GG
[J]. CELL, 1989, 57 (02) : 277 - 285
[4] ERSLEV AJ, 1987, J LAB CLIN MED, V109, P429
[5] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL
ESCHBACH, JW
EGRIE, JC
DOWNING, MR
BROWNE, JK
ADAMSON, JW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78
[6] RECOMBINANT HUMAN ERYTHROPOIETIN IN ANEMIC PATIENTS WITH END-STAGE RENAL-DISEASE - RESULTS OF A PHASE-III MULTICENTER CLINICAL-TRIAL
ESCHBACH, JW
ABDULHADI, MH
BROWNE, JK
DELANO, BG
DOWNING, MR
EGRIE, JC
EVANS, RW
FRIEDMAN, EA
GRABER, SE
HALEY, NR
KORBET, S
KRANTZ, SB
LUNDIN, AP
NISSENSON, AR
OGDEN, DA
PAGANINI, EP
RADER, B
RUTSKY, EA
STIVELMAN, J
STONE, WJ
TESCHAN, P
VANSTONE, JC
VANWYCK, DB
ZUCKERMAN, K
ADAMSON, JW
[J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) : 992 - 1000
[7] EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825
[8] GASSON DW, 1988, SCI AM, V259, P62
[9] HENRY DH, 1989, BLOOD S, V74, pA6
[10] SERUM IMMUNOREACTIVE ERYTHROPOIETIN IN RHEUMATOID-ARTHRITIS - IMPAIRED RESPONSE TO ANEMIA
HOCHBERG, MC
ARNOLD, CM
HOGANS, BB
SPIVAK, JL
[J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (10): : 1318 - 1321

← 1 2 3 →